These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15536143)

  • 1. Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation.
    Chapman SA; Gilkerson KL; Davin TD; Pritzker MR
    Ann Pharmacother; 2004 Dec; 38(12):2059-67. PubMed ID: 15536143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute renal failure following treatment with intravenously administered immunoglobulins].
    van Zanten AR; Beekhuyzen M; van der Meer YG; de Gooijer A; Feith GW
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):307-10. PubMed ID: 12622009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reemergence of sucrose nephropathy: acute renal failure caused by high-dose intravenous immune globulin therapy.
    Zhang R; Szerlip HM
    South Med J; 2000 Sep; 93(9):901-4. PubMed ID: 11005352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy.
    Daphnis E; Stylianou K; Alexandrakis M; Xylouri I; Vardaki E; Stratigis S; Kyriazis J
    Nephron Clin Pract; 2007; 106(4):c143-8. PubMed ID: 17596722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute kidney failure secondary to intravenous immunoglobulin administration. 4 cases and review of the literature].
    Decocq G; de Cagny B; Andréjak M; Desablens B
    Therapie; 1996; 51(5):516-26. PubMed ID: 9138386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report.
    Winward DB; Brophy MT
    Pharmacotherapy; 1995; 15(6):765-72. PubMed ID: 8602385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobinuria and acute kidney injury requiring hemodialysis following intravenous immunoglobulin infusion.
    Welles CC; Tambra S; Lafayette RA
    Am J Kidney Dis; 2010 Jan; 55(1):148-51. PubMed ID: 19628320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience.
    Vo AA; Cam V; Toyoda M; Puliyanda DP; Lukovsky M; Bunnapradist S; Peng A; Yang K; Jordan SC
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):844-52. PubMed ID: 17699296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute renal failure resulting from intravenous immunoglobulin therapy.
    Wajanaponsan N; Cheng SF
    Hawaii Med J; 2004 Sep; 63(9):266-7. PubMed ID: 15540524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute renal failure after large doses of intravenous immune globulin.
    Haskin JA; Warner DJ; Blank DU
    Ann Pharmacother; 1999; 33(7-8):800-3. PubMed ID: 10466908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case-control study.
    Moulis G; Sailler L; Sommet A; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):314-9. PubMed ID: 21953992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin induced-nephropathy: a complication of IVIG therapy.
    Ahsan N
    J Nephrol; 1998; 11(3):157-61. PubMed ID: 9650125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura.
    Chun NS; Savani B; Seder RH; Taplin ME
    Am J Hematol; 2003 Dec; 74(4):276-9. PubMed ID: 14635210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of intravenous immunoglobulin (IVIG) therapy.
    Katz U; Achiron A; Sherer Y; Shoenfeld Y
    Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case report: acute renal failure after administering intravenous immunoglobulin.
    Graumann A; Zawada ET
    Postgrad Med; 2010 Mar; 122(2):142-7. PubMed ID: 20203465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulins: in-depth review of excipients and acute kidney injury risk.
    Dantal J
    Am J Nephrol; 2013; 38(4):275-84. PubMed ID: 24051350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia.
    Subtirelu MM; Flynn JT; Schechner RS; Pullman JM; Feuerstein D; Del Rio M
    Pediatr Transplant; 2005 Dec; 9(6):801-4. PubMed ID: 16269055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute renal failure after high-dose intravenous immune globulin in a patient with idiopathic thrombocytopenic purpura.
    Ruggeri M; Castaman G; De Nardi G; Rodeghiero F
    Haematologica; 1993; 78(5):338-9. PubMed ID: 8314166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute renal failure following intravenous administration of hepatitis B im-munoglobulin in liver transplantation.
    Donataccio M; Dalle Ore G; Donataccio D
    Minerva Gastroenterol Dietol; 2009 Dec; 55(4):501-4. PubMed ID: 19942832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.